Publications by authors named "Marion Moos"

Claim this Profile
H
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, Axel Benner, Marion Moos

Blood· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.
Niels Weinhold, Jerome Moreaux, Marc S Raab, Dirk Hose, Thomas Hielscher, Marion Moos

Genes Chromosomes Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Olaf Christensen, Alaviana Lupu, Stefanie Schmidt, Maud Condomines, Sebastian Belle, Marion Moos

J Immunother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
Sebastian Belle, Fang Han, Maud Condomines, Olaf Christensen, Mathias Witzens-Harig, Marion Moos

Eur J Haematol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
Tilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, Christiane Heiss, Axel Benner, Marion Moos

Blood· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Jérôme Moreaux, Dirk Hose, Michel Jourdan, Thierry Reme, Michael Hundemer, Marion Moos

Haematologica· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.
Maud Condomines, Dirk Hose, Pierre Raynaud, Michael Hundemer, John De Vos, Marion Moos

J Immunol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD200 is a new prognostic factor in multiple myeloma.
Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Marion Moos

Blood· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Michael Hundemer, Stefanie Schmidt, Maud Condomines, Alaviana Lupu, Dirk Hose, Marion Moos

Exp Hematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.
Friedrich W Cremer, Jelena Bila, Isabelle Buck, Mutlu Kartal, Dirk Hose, Marion Moos

Genes Chromosomes Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
Friedrich W Cremer, Mutlu Kartal, Dirk Hose, Jelena Bila, Isabelle Buck, Marion Moos

Cancer Genet Cytogenet· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.
Jérôme Moreaux, Friedrich W Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Marion Moos

Blood· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Carina Lotz, Sarah Abdel Mutallib, Nicole Oehlrich, Ulrike Liewer, Edite Antunes Ferreira, Marion Moos

J Immunol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
Karène Mahtouk, Dirk Hose, Thierry Rème, John De Vos, Michel Jourdan, Marion Moos

Oncogene· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma.
Marleen H C Bakkus, Yasmina Bouko, Diana Samson, Jane F Apperley, Kris Thielemans, Marion Moos

Br J Haematol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasensitive PCR detection of tumor cells in myeloma.
Friedrich W Cremer, Marion Moos

Methods Mol Biol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
Thomas Luft, Marion Moos, Hartmut Goldschmidt, Anthony D Ho, Martin Görner

Br J Haematol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis